DYADIC INTERNATIONAL, INC.

(DYAI)
  Report
Delayed Nasdaq  -  05/18 04:00:00 pm EDT
2.130 USD   -8.58%
05/12TRANSCRIPT : Dyadic International, Inc., Q1 2022 Earnings Call, May 12, 2022
CI
05/12DYADIC INTERNATIONAL INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
05/12Dyadic International, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Dyadic Says C1-Cells Have Potential to Produce Cannabis Compounds Using Synthetic Biology; Shares Gain

01/20/2022 | 10:16am EDT


ę MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
AURORA CANNABIS INC. -6.06% 3.72 Delayed Quote.-42.19%
AUXLY CANNABIS GROUP INC. 0.00% 0.155 Delayed Quote.-16.22%
CANOPY GROWTH CORPORATION -4.77% 7.18 Delayed Quote.-31.70%
CRONOS GROUP INC. -5.91% 4.3 Delayed Quote.-8.23%
DYADIC INTERNATIONAL, INC. -8.58% 2.13 Delayed Quote.-52.88%
HEXO CORP. -12.05% 0.365 Delayed Quote.-52.84%
ORGANIGRAM HOLDINGS INC. -9.83% 1.56 Delayed Quote.-22.07%
THE GREEN ORGANIC DUTCHMAN HOLDINGS LTD. -5.00% 0.095 Delayed Quote.5.26%
All news about DYADIC INTERNATIONAL, INC.
05/12TRANSCRIPT : Dyadic International, Inc., Q1 2022 Earnings Call, May 12, 2022
CI
05/12DYADIC INTERNATIONAL INC Management's Discussion and Analysis of Financial Condition a..
AQ
05/12Dyadic International, Inc. Reports Earnings Results for the First Quarter Ended March 3..
CI
05/12Dyadic Reports First Quarter 2022 Financial Results and Highlights Recent Company Devel..
AQ
05/11Dyadic International Enters Collaboration to Develop Animal-Free Ingredient Products
MT
05/11DYADIC INTERNATIONAL INC : Entry into a Material Definitive Agreement, Other Events, Finan..
AQ
05/11Dyadic International, Inc. Enters into Joint Development Agreement with Global Food Ing..
CI
05/11Dyadic Announces Research, License and Collaboration for the Manufacture of Animal Free..
GL
05/11Dyadic Announces Research, License and Collaboration for the Manufacture of Animal Free..
AQ
05/09Dyadic Announces Successful Toxicology Data Published in “Toxicologic Pathology&..
GL
More news
Analyst Recommendations on DYADIC INTERNATIONAL, INC.
More recommendations
Financials (USD)
Sales 2022 9,50 M - -
Net income 2022 -8,20 M - -
Net Debt 2022 - - -
P/E ratio 2022 -8,32x
Yield 2022 -
Capitalization 65,9 M 65,9 M -
Capi. / Sales 2022 6,93x
Capi. / Sales 2023 5,07x
Nbr of Employees 7
Free-Float 49,1%
Chart DYADIC INTERNATIONAL, INC.
Duration : Period :
Dyadic International, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DYADIC INTERNATIONAL, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 2,33 $
Average target price 7,50 $
Spread / Average Target 222%
EPS Revisions
Managers and Directors
Mark A. Emalfarb President, Chief Executive Officer & Director
Ping W. Rawson Chief Accounting Officer
Michael P. Tarnok Chairman
Ronen Tchelet Vice President-Research & Business Development
Seth J. Herbst Independent Director
Sector and Competitors
1st jan.Capi. (M$)
DYADIC INTERNATIONAL, INC.-48.45%66
MODERNA, INC.-43.98%56 593
LONZA GROUP AG-27.42%41 313
IQVIA HOLDINGS INC.-26.74%39 122
SEAGEN INC.-5.21%26 976
ICON PUBLIC LIMITED COMPANY-32.47%17 002